Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare ...

The Dutch fashion retailer’s Omoda Stylist platform leverages Google Cloud’s Vertex AI platform and Gemini models for a tailored shopping experience.

This collaboration is set to revolutionize the industrial mobile communications landscape by introducing intrinsically safe ...

Hitachi Vantara, the data storage, infrastructure, and hybrid cloud management subsidiary of Hitachi, Ltd. (TSE: 6501), today announced that Malayala Manorama, India's second-largest newspaper by ...

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research ...

Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though ...

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...

Lodestone Energy has energised the 42MW Te Herenga o Te Rā solar PV plant in the Bay of Plenty on New Zealand’s northern ...

Vertex Pharmaceuticals Inc. closed 18.39% short of its 52-week high of $519.88, which the company reached on November 8th.

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...